Annales d'endocrinologie最新文献_第4页

Key data from the 2024 European Thyroid Association annual meeting: Thyroid nodule management

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2025-01-13 DOI: 10.1016/j.ando.2025.101686

Geneviève Crouzeix , Philippe Caron

引用次数: 0

Giant parathyroid adenoma: A case report and literature review

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2025-01-13 DOI: 10.1016/j.ando.2025.101684

Saïd Haddadi , Ladjel Khelafi , Rabah Ourdane , Amira Bouchenna , Rezki Touati

引用次数: 0

Key data from the 2024 European Thyroid Association annual meeting: Autoimmune thyroid diseases

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2025-01-11 DOI: 10.1016/j.ando.2025.101683

Solange Grunenwald, Philippe Caron

引用次数: 0

Increased cardiovascular risk despite unchanged body composition in non functional adrenal incidentaloma NFAI患者尽管身体成分不变，但心血管风险增加。

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2025-01-11 DOI: 10.1016/j.ando.2025.101687

Alperen Boyraz , Burcu Candemir , Şafak Akın , Mustafa Candemir , Neşe Ersöz Gülçelik

{"title":"Increased cardiovascular risk despite unchanged body composition in non functional adrenal incidentaloma","authors":"Alperen Boyraz , Burcu Candemir , Şafak Akın , Mustafa Candemir , Neşe Ersöz Gülçelik","doi":"10.1016/j.ando.2025.101687","DOIUrl":"10.1016/j.ando.2025.101687","url":null,"abstract":"<div><h3>Background</h3><div>Non-functional adrenal incidentaloma (NFAI) is associated with an increased risk of adverse cardiometabolic outcome. Identifying predictors of atherosclerotic cardiovascular disease (ASCVD) may enable more appropriate management strategies in patients with NFAI. We aimed to investigate the body composition parameters and ASCVD risk in patients with NFAI.</div></div><div><h3>Methods</h3><div>Eighty patients with NFAI and 80 controls matched for age, gender and body mass index (BMI) were included. ASCVD risk was assessed on Framingham Risk Score (FRS) and American Heart Association/American College of Cardiology (AHA/ACC) score. Body composition was evaluated using a segmental body composition analyzer.</div></div><div><h3>Results</h3><div>There were no significant differences in age, gender, blood pressure or body composition parameters between the two groups. Patients with NFAI had higher FRS and AHA/ACC scores than controls (<em>P</em>  =0.024, respectively). In patients with NFAI, independent predictors for FRS were serum cortisol level after 1mg dexamethasone suppression test (DST) and waist/hip ratio (WHR), while independent predictors for AHA/ACC score were serum cortisol level after 1mg DST, WHR and fasting plasma glucose (FPG), in various multivariate linear regression models.</div></div><div><h3>Conclusions</h3><div>FRS and AHA/ACC scores may be useful in determining ASCVD risk in patients with NFAI, and serum cortisol level after 1mg DST is an independent predictor of ASCVD in these patients, even in the absence of hypercortisolism.</div></div>","PeriodicalId":7917,"journal":{"name":"Annales d'endocrinologie","volume":"86 2","pages":"Article 101687"},"PeriodicalIF":2.9,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Key data from the 2024 European Thyroid Association Congress. Graves’ orbitopathy: Old recipes or new cuisine? 来自2024年欧洲甲状腺协会大会的关键数据。格雷夫斯眼病：旧食谱还是新食谱？

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2025-01-08 DOI: 10.1016/j.ando.2025.101682

Miriam Ladsous , Philippe Caron

引用次数: 0

Diagnosis of acromegaly based on inaugural orbitopathy 基于初始眼窝病的肢端肥大症诊断。

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2024-12-27 DOI: 10.1016/j.ando.2024.101679

Yannick Rivoal , Augustin Lecler , Mathieu Zmuda , Marie Callet , Olivier Galatoire

引用次数: 0

Key data from the 2024 European Thyroid Association annual meeting: “Thyroid and pregnancy” 来自2024年欧洲甲状腺协会年会的关键数据：“甲状腺与妊娠”。

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2024-12-27 DOI: 10.1016/j.ando.2024.101681

Philippe Caron

引用次数: 0

Tatton-Brown-Rahman syndrome: A new multiple endocrine neoplasia syndrome with intellectual disability? 塔顿-布朗-拉赫曼综合征：一种新的智力残疾多发性内分泌瘤变综合征？

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2024-12-27 DOI: 10.1016/j.ando.2024.101680

Lauriane Le Collen , Théo Charnay , Sang Ly , Brigitte Delemer , Arnaud Lagarde , Giuliana Ascone , Adrian F. Daly , Anne Barlier , Pauline Romanet , AURAGEN consortium

引用次数: 0

Desmopressin is a safe and effective secretagogue to replace corticotropin-releasing hormone in petrosal sinus sampling 去氨加压素是一种安全有效的促肾上腺皮质激素释放激素替代物。

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2024-12-19 DOI: 10.1016/j.ando.2024.101678

Cecilia Piazzola , Thomas Graillon , Nadine Girard , Henry Dufour , Thierry Brue , Frederic Castinetti

{"title":"Desmopressin is a safe and effective secretagogue to replace corticotropin-releasing hormone in petrosal sinus sampling","authors":"Cecilia Piazzola , Thomas Graillon , Nadine Girard , Henry Dufour , Thierry Brue , Frederic Castinetti","doi":"10.1016/j.ando.2024.101678","DOIUrl":"10.1016/j.ando.2024.101678","url":null,"abstract":"<div><h3>Purpose</h3><div>Bilateral inferior petrosal sinus sampling (BIPSS) with corticotropin-releasing hormone (CRH) was the gold standard for distinguishing Cushing disease (CD) from ectopic ACTH secretion (EAS). CRH, however, is no longer available.</div></div><div><h3>Objective</h3><div>To assess the reliability of BIPSS with desmopressin to differentiate CD from EAS.</div></div><div><h3>Methods</h3><div>A retrospective study included patients who underwent BIPSS with desmopressin for ACTH-dependent hypercortisolism, with the whole diagnostic procedure in a single center.</div></div><div><h3>Results</h3><div>Fifty-eight patients with confirmed etiological diagnosis were included: 51 CD, 7 EAS. Forty-three CD patients (84.3%) had post-stimulation ratio ≥2 before stimulation and 6 of the other 8 (75%) had a ratio ≥3. All EAS patients were correctly diagnosed before and after stimulation. Sensitivity was 84.3% before stimulation and 92.2% combining pre- and post-stimulation results; specificity reached 100%. A ROC curve established optimal thresholds at 1.4 before stimulation and 1.7 after.</div></div><div><h3>Conclusion</h3><div>Desmopressin is a good substitute for CRH, correcting diagnosis compared to baseline BIPSS in 12% of cases.</div></div>","PeriodicalId":7917,"journal":{"name":"Annales d'endocrinologie","volume":"86 2","pages":"Article 101678"},"PeriodicalIF":2.9,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluation of the analytic performance and macroprolactin sensitivity of a new prolactin immunoassay 新型催乳素免疫分析法分析性能及催乳素敏感性评价。

IF 2.9 3区医学

Annales d'endocrinologie Pub Date : 2024-12-07 DOI: 10.1016/j.ando.2024.101677

Guillaume David , Pauline Perrin , Camille Sergeant , Gérald Raverot , Véronique Raverot

{"title":"Evaluation of the analytic performance and macroprolactin sensitivity of a new prolactin immunoassay","authors":"Guillaume David , Pauline Perrin , Camille Sergeant , Gérald Raverot , Véronique Raverot","doi":"10.1016/j.ando.2024.101677","DOIUrl":"10.1016/j.ando.2024.101677","url":null,"abstract":"<div><h3>Purpose</h3><div>Prolactin measurement is essential in endocrine diagnostics. Challenges such as the hook effect and reactivity to macroprolactin, which varies according to the reagent, complicate accurate measurement. The present study evaluated a newly marketed reagent to detect prolactin, IDS Prolactin, comparing it to an established reagent, Roche Elecsys Prolactin, assessing its behavior toward macroprolactin and polyethylene glycol (PEG) treatment, and establishing reference intervals.</div></div><div><h3>Methods</h3><div>The IDS Prolactin and Roche Elecsys Prolactin assays were compared using 44 samples containing macroprolactin confirmed on gel filtration chromatography (macroprolactin: BBPRL) and 104 samples for which the diagnosis of macroprolactin was excluded (monomeric prolactin: MNPRL). Analytic performance of the IDS Prolactin assay was also assessed.</div></div><div><h3>Results</h3><div>The new reagent showed satisfactory analytic performance, meeting EFLM standards for repeatability and intermediate imprecision. Comparison between the two methods found robust correlation for monomeric samples (y=1.060x–18.28; r<sup>2</sup>   <!-->μg/L) for post-PEG monomeric prolactin upper limit of normal. Reference intervals were established for women, with ROC curve analysis demonstrating high sensitivity and specificity.</div></div><div><h3>Conclusion</h3><div>The IDS Prolactin assay showed excellent analytic performance and satisfactory characteristics on macroprolactinemic samples.</div></div>","PeriodicalId":7917,"journal":{"name":"Annales d'endocrinologie","volume":"86 2","pages":"Article 101677"},"PeriodicalIF":2.9,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0